A silk-based platform to stabilize phenylalanine ammonia-lyase (PAL) for orally administered enzyme replacement therapy
L. d'Amone, V. D. Trivedi, N. U. Nair, F. G. Omenetto
This paper describes a silk-based platform that stabilizes PAL for oral enzyme replacement therapy in PKU patients.
bioRxiv · Apr 14, 2022Bioengineering